Low-Dose Naltrexone (LDN) for Fibromyalgia, CRPS, and Central Sensitisation

Wessex Pain Clinic

Low-Dose Naltrexone (LDN) for Fibromyalgia, CRPS, and Central Sensitisation

Low-dose naltrexone (LDN) is an emerging treatment option used to help manage persistent pain conditions such as fibromyalgia, Complex Regional Pain Syndrome (CRPS), and other syndromes linked to central sensitisation — where the nervous system becomes overly sensitive to pain. At Wessex Pain Clinic, LDN may be considered as part of a broader, multidisciplinary plan when standard treatments have provided only partial relief.

How the Procedure Works

Naltrexone is a medication originally used in higher doses to treat opioid or alcohol dependence. When given in very small doses (typically one-tenth or less of the standard amount), it appears to act quite differently — helping to modulate inflammation and pain sensitivity within the nervous system.

LDN is not an opioid and does not cause dependence or withdrawal.

Wessex Pain Clinic

What Conditions It Can Help With

LDN may be considered for patients with:
Fibromyalgia – widespread musculoskeletal pain, fatigue, and sensitivity
Complex Regional Pain Syndrome (CRPS) – persistent, severe pain following injury or surgery
Central sensitisation syndromes – where the nervous system becomes hypersensitive, amplifying pain signals
Other persistent neuropathic pain conditions not responding well to standard therapy

Aimed Benefits

The aim of low-dose naltrexone therapy is to reduce pain sensitivity, improve energy, and enhance overall wellbeing. Many patients also report better sleep and mood, which can support broader recovery.

Effects often develop gradually over several weeks. While not every patient responds, those who do may experience sustained improvements that allow better participation in physiotherapy, activity, and self-management.

What to Expect

If LDN is considered appropriate, your consultant will start you on a very low dose, which may be increased gradually depending on response and tolerability.

Risks and Considerations

All medications carry potential risks. LDN should not be taken alongside opioid-based painkillers, as it blocks their effects. It may also cause unpredictable responses to opioid based medications. Your consultant will review your current medications carefully to ensure suitability. You will have the opportunity to ask questions, and formal consent will always be obtained before treatment begins.

Combined Approach / Multidisciplinary Care

At Wessex Pain Clinic we find that the best results come from combining medical treatments with active rehabilitation. LDN is often most effective when paired with physiotherapy, pacing and movement-based exercise, and — where appropriate — psychological support. This comprehensive approach addresses both the physical and emotional aspects of pain and supports longer-term improvement.

Key Points Summary

  • Consultant-supervised therapy using very low doses of naltrexone
  • May help reduce pain sensitivity in fibromyalgia, CRPS, and central sensitisation
  • Non-opioid treatment
  • Gradual onset of benefit over several weeks
  • Supplied via specialist pharmacy under supervision
  • Works best as part of a multidisciplinary pain management plan

Disclaimer

Results vary between individuals and cannot be guaranteed. Your consultant will discuss whether this treatment is appropriate for you.

At Wessex Pain Clinic, we work as a team and meet regularly to discuss complex, treatment resistant or unusual cases. As such you will often receive the expertise of several pain consultants. We believe that we are one of very few pain clinics to offer this. Wessex Pain Clinic provides consultant-led assessment and treatment for acute and chronic pain conditions. Our multidisciplinary team includes Consultant Pain Specialists, Physiotherapists and Psychologists, offering evidence-based interventions alongside rehabilitation and self-management support. We welcome patients from across Hampshire, Dorset, Wiltshire, Surrey and Sussex, including Winchester, Basingstoke, Southampton, Portsmouth, and Chichester – with both in-clinic appointments and remote consultations available across the wider Wessex region.